ArticleBiomarker research2025
Machine learning-based radiomics model: prognostic prediction and mechanism exploration in patients with endometrial cancer.
Article in Biomarker research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Integrating artificial intelligence and multi-omics data for precision oncology in endometrial cancer: a narrative review.Functional & integrative genomics · 2026Review
- Interpretable machine learning for Parkinson's disease diagnosis, staging, and biological mechanism exploration: a multicenter analysis.BioData mining · 2026Article
- A systems microbiology framework for reproducible multi-dataset omics integration with application to long COVID.Frontiers in systems biology · 2026Article
- A Clinicopathology and Simplified Molecular Marker-Based Risk Stratification Model for Predicting 3-Year Recurrence in Endometrial Cancer.Clinical Medicine Insights. Oncology · 2026Article
- Multimodal deep learning fusion model for assessment of fetal lung development in gestational diabetes mellitus and pre-eclampsia.Frontiers in endocrinology · 2026Article
- Development and validation of a machine learning-based pathomics nomogram for prognostic prediction in endometrial cancer.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesTo investigate the predictive value of machine-learning-based Radiomics models for postoperative overall survival (OS) of endometrial cancer (EC) patients and their biological mechanisms.
methodsData from 469 patients with endometrial cancer in three Centers (271 in Center 1, 154 in Center 2, and 44 in Center 3) were retrospectively and 90 patients in Center 1 were prospectively analyzed. Three-dimensional Radiomics parameters of the primary lesion and its surrounding 5 mm region in T2WI were collected from all patients. Ten machine learning methods were used to calculate the optimal Radiomics score (Radscore), whose incremental value to the available clinical indexes, pathomics, transcriptomics, and proteomics were revealed. Eventually, TCGA and CPTAC were used for the exploration of biological mechanisms of Radiomics model, with experimental validation.
resultsRadiomics features of tumor and peritumor showed some complementarity in the prognostic prediction of EC patients. The best predictive efficacy was demonstrated by the combined Radiomics model based on XGboost, with AUCs of 0.862, 0.885, 0.870 (validation set) and 0.823, 0.869, 0.849 (test set 1) and 0.850, 0.731, 0.800 (test set 2). Radiomics models demonstrated high incremental value to existing clinical indicators and can effectively improve prognostic prediction. In addition, Radiomics models have been shown to have synergistic prognostic predictive potential with pathomics, transcriptomics, and proteomics. Finally, mechanical explorations suggest that Radiomics models may be associated with tumor angiogenesis-related pathways, of which FLT1 was highlighted.
conclusionsMachine learning-based Radiomics model contributes to predicting postoperative OS in EC patients and suggests a correlation with tumor angiogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.